{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T22:09:35Z","timestamp":1771279775757,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-025-10302-5","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:27:38Z","timestamp":1769563658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study"],"prefix":"10.1007","volume":"34","author":[{"given":"Rodolfo","family":"Mauceri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"La Mantia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Di Fede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Marcian\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Coppini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Seminara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Panzarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Coniglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Tozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Matranga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"10302_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ODI.14887","author":"A Bedogni","year":"2024","unstructured":"Bedogni A, Mauceri R, Fusco V et al (2024) Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). Oral Dis. https:\/\/doi.org\/10.1111\/ODI.14887","journal-title":"Oral Dis"},{"key":"10302_CR2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/CLINEM\/DGAB888","volume":"107","author":"AD Anastasilakis","year":"2022","unstructured":"Anastasilakis AD, Pepe J, Napoli N et al (2022) Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. J Clin Endocrinol Metab 107:1441\u20131460. https:\/\/doi.org\/10.1210\/CLINEM\/DGAB888","journal-title":"J Clin Endocrinol Metab"},{"key":"10302_CR3","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/S00520-020-05855-6","volume":"29","author":"R Querrer","year":"2021","unstructured":"Querrer R, Ferrare N, Melo N et al (2021) Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review. Support Care Cancer 29:2811\u20132820. https:\/\/doi.org\/10.1007\/S00520-020-05855-6","journal-title":"Support Care Cancer"},{"key":"10302_CR4","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186\/ASSET\/CFAE724D-80C9-4793-95DE-9A12BF686FFB\/ASSETS\/IMAGES\/LARGE\/JCO.19.01186TA1.JPG","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE et al (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol 37:2270\u20132290. https:\/\/doi.org\/10.1200\/JCO.19.01186\/ASSET\/CFAE724D-80C9-4793-95DE-9A12BF686FFB\/ASSETS\/IMAGES\/LARGE\/JCO.19.01186TA1.JPG","journal-title":"J Clin Oncol"},{"key":"10302_CR5","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/S00520-020-05440-X","volume":"28","author":"L Drudge-Coates","year":"2020","unstructured":"Drudge-Coates L, Van den Wyngaert T, Schi\u00f8dt M et al (2020) Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Support Care Cancer 28:4019. https:\/\/doi.org\/10.1007\/S00520-020-05440-X","journal-title":"Support Care Cancer"},{"key":"10302_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic [1]. J Oral Maxillofac Surg 61:1115\u20131117. https:\/\/doi.org\/10.1016\/S0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"key":"10302_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534. https:\/\/doi.org\/10.1016\/j.joms.2004.02.004","journal-title":"J Oral Maxillofac Surg"},{"key":"10302_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/J.1600-051X.2005.00842.X","volume":"32","author":"G Ficarra","year":"2005","unstructured":"Ficarra G, Beninati F, Rubino I et al (2005) Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32:1123\u20131128. https:\/\/doi.org\/10.1111\/J.1600-051X.2005.00842.X","journal-title":"J Clin Periodontol"},{"key":"10302_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/jbmr.379","volume":"26","author":"TL Aghaloo","year":"2011","unstructured":"Aghaloo TL, Kang B, Sung EC et al (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 26:1871\u20131882. https:\/\/doi.org\/10.1002\/jbmr.379","journal-title":"J Bone Miner Res"},{"key":"10302_CR10","doi-asserted-by":"publisher","unstructured":"(2007) American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofacial Surg 65:369\u2013376. https:\/\/doi.org\/10.1016\/j.joms.2006.11.003","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"10302_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.CRITREVONC.2006.12.005","volume":"62","author":"R Weitzman","year":"2007","unstructured":"Weitzman R, Sauter N, Eriksen EF et al (2007) Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients-May 2006. Crit Rev Oncol Hematol 62:148\u2013152. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2006.12.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10302_CR12","unstructured":"Raccomandazione n. 10 - Raccomandazione per la prevenzione dell\u2019osteonecrosi della mascella\/mandibola da bifosfonati. https:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_2_1.jsp?lingua=italiano&id=1077. Accessed 16 Jul 2024"},{"key":"10302_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.oooo.2015.08.007","volume":"120","author":"O Nicolatou-Galitis","year":"2015","unstructured":"Nicolatou-Galitis O, Razis E, Galiti D et al (2015) Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: Report of 5 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 120:699\u2013706. https:\/\/doi.org\/10.1016\/j.oooo.2015.08.007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10302_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/JOP.12963","volume":"49","author":"AI Lorenzo-Pouso","year":"2020","unstructured":"Lorenzo-Pouso AI, P\u00e9rez-Say\u00e1ns M, Chamorro-Petronacci C et al (2020) Association between periodontitis and medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. J Oral Pathol Med 49:190\u2013200. https:\/\/doi.org\/10.1111\/JOP.12963","journal-title":"J Oral Pathol Med"},{"key":"10302_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/CRE2.775","volume":"9","author":"A Alrmali","year":"2023","unstructured":"Alrmali A, Saleh MHA, Kurdi SMS et al (2023) Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: a clinical feasibility study. Clin Exp Dent Res 9:791\u2013798. https:\/\/doi.org\/10.1002\/CRE2.775","journal-title":"Clin Exp Dent Res"},{"key":"10302_CR16","doi-asserted-by":"publisher","unstructured":"Beth-Tasdogan NH, Mayer B, Hussein H, et al (2022) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database of Systematic Reviews 2022:. https:\/\/doi.org\/10.1002\/14651858.CD012432.PUB3\/MEDIA\/CDSR\/CD012432\/IMAGE_N\/NCD012432-CMP-007.01.SVG","DOI":"10.1002\/14651858.CD012432.PUB3\/MEDIA\/CDSR\/CD012432\/IMAGE_N\/NCD012432-CMP-007.01.SVG"},{"key":"10302_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/J.CTRV.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T et al (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177\u2013187. https:\/\/doi.org\/10.1016\/J.CTRV.2018.06.007","journal-title":"Cancer Treat Rev"},{"key":"10302_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ADJ.13050","volume":"70","author":"YS Chang","year":"2025","unstructured":"Chang YS, Nanayakkara S, Yaacoub A, Cox SC (2025) Prevention of medication-related osteonecrosis of the jaw: institutional insights from a retrospective study. Aust Dent J 70:70\u201377. https:\/\/doi.org\/10.1111\/ADJ.13050","journal-title":"Aust Dent J"},{"key":"10302_CR19","doi-asserted-by":"publisher","unstructured":"Greene JC, Vermillion JR (1964) THE SIMPLIFIED ORAL HYGIENE INDEX. J Am Dent Assoc 68:7\u201313. https:\/\/doi.org\/10.14219\/jada.archive.1964.0034","DOI":"10.14219\/jada.archive.1964.0034"},{"key":"10302_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2217\/FON.13.211","volume":"10","author":"G Campisi","year":"2014","unstructured":"Campisi G, Fedele S, Fusco V et al (2014) Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol 10:257\u2013275. https:\/\/doi.org\/10.2217\/FON.13.211","journal-title":"Future Oncol"},{"key":"10302_CR21","unstructured":"A. Bedogni, G. Campisi, V. Fusco, A. Agrillo (2013) Raccomandazioni clinico-terapeutiche sull\u2019osteonecrosi delle ossa mascellari associata a bisfosfonati e sua prevenzione. https:\/\/www.policlinico.pa.it\/portal\/pdf\/promaf\/5.Allegato%2020-RACCOMANDAZIONI%20PER%20PREVENZIONE%20E%20CURA%20DELLA%20OSTEONECROSI%20DELLE%20OSSA%20MASCELLARI-%20BEDOGNI%20CAMPISI%20FUSCO%20MONOGRAFIA_%20ONJ%20-AGRILLO-OPEN%20ACCESS%20-GENNAIO%202014%20vers.1.1.pdf. Accessed 23 Jul 2024"},{"key":"10302_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1902\/ANNALS.1999.4.1.1","volume":"4","author":"GC Armitage","year":"1999","unstructured":"Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Annals periodontology \/ the American Academy Periodontology 4:1\u20136. https:\/\/doi.org\/10.1902\/ANNALS.1999.4.1.1","journal-title":"Annals periodontology \/ the American Academy Periodontology"},{"key":"10302_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/J.1601-0825.2012.01903.X","volume":"18","author":"A Bedogni","year":"2012","unstructured":"Bedogni A, Fusco V, Agrillo A, Campisi G (2012) Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Dis 18:621\u2013623. https:\/\/doi.org\/10.1111\/J.1601-0825.2012.01903.X","journal-title":"Oral Dis"},{"key":"10302_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/ODI.12842","volume":"24","author":"JA Coello-Suanzes","year":"2018","unstructured":"Coello-Suanzes JA, Rollon-Ugalde V, Casta\u00f1o-Seiquer A et al (2018) Preventive dental management of osteonecrosis of the jaws related to zoledronic acid treatment. Oral Dis 24:1029\u20131036. https:\/\/doi.org\/10.1111\/ODI.12842","journal-title":"Oral Dis"},{"key":"10302_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/J.JOMS.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T et al (2022) American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update. J Oral Maxillofac Surg 80:920\u2013943. https:\/\/doi.org\/10.1016\/J.JOMS.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"10302_CR26","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.joms.2022.07.143","volume":"80","author":"V Fusco","year":"2022","unstructured":"Fusco V, Mauceri R, Campisi G, Bedogni A (2022) RE: American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update: quantitative risk assessment and controversial issues. J Oral Maxillofac Surg 80:1871\u20131873. https:\/\/doi.org\/10.1016\/j.joms.2022.07.143","journal-title":"J Oral Maxillofac Surg"},{"key":"10302_CR27","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1007\/S00520-022-06839-4","volume":"30","author":"H Hata","year":"2022","unstructured":"Hata H, Imamachi K, Ueda M et al (2022) Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study. Support Care Cancer 30:4505\u20134514. https:\/\/doi.org\/10.1007\/S00520-022-06839-4","journal-title":"Support Care Cancer"},{"key":"10302_CR28","doi-asserted-by":"publisher","first-page":"ee42","DOI":"10.4317\/MEDORAL.21728","volume":"22","author":"M Manfredi","year":"2017","unstructured":"Manfredi M, Mergoni G, Goldoni M et al (2017) A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors. Med Oral Patol Oral Cir Bucal 22:ee42. https:\/\/doi.org\/10.4317\/MEDORAL.21728","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10302_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/J.OOOO.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho AA, Liang STY, Sax AZ et al (2018) Medication-related osteonecrosis of the jaw (MRONJ): An update on the Memorial Sloan Kettering Cancer Center (MSKCC) experience and the role of Pre-medication Dental Evaluation in the prevention of MRONJ. Oral Surg Oral Med Oral Pathol Oral Radiol 125:440. https:\/\/doi.org\/10.1016\/J.OOOO.2018.02.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10302_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","volume":"127","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes RA et al (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127:117\u2013135. https:\/\/doi.org\/10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10302_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS251910488","volume":"25","author":"B Bojtor","year":"2024","unstructured":"Bojtor B, Balla B, Vaszilko M et al (2024) Genetic background of medication-related osteonecrosis of the jaw: current evidence and future perspectives. Int J Mol Sci 25:10488. https:\/\/doi.org\/10.3390\/IJMS251910488","journal-title":"Int J Mol Sci"},{"key":"10302_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/S00520-021-06634-7","volume":"30","author":"H Ikesue","year":"2021","unstructured":"Ikesue H, Doi K, Morimoto M et al (2021) Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score\u2013matched analysis. Support Care Cancer 30:2341. https:\/\/doi.org\/10.1007\/S00520-021-06634-7","journal-title":"Support Care Cancer"},{"issue":"9","key":"10302_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS24097948","volume":"24","author":"I Roato","year":"2023","unstructured":"Roato I, Mauceri R, Notaro V et al (2023) Immune dysfunction in medication-related osteonecrosis of the jaw. Int J Mol Sci 24(9):7948. https:\/\/doi.org\/10.3390\/IJMS24097948","journal-title":"Int J Mol Sci"},{"key":"10302_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/MEDICINA57050463","author":"S Otto","year":"2021","unstructured":"Otto S, Aljohani S, Fliefel R et al (2021) Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina (Kaunas). https:\/\/doi.org\/10.3390\/MEDICINA57050463","journal-title":"Medicina (Kaunas)"},{"key":"10302_CR35","doi-asserted-by":"crossref","unstructured":"Mauceri R, Coniglio R, Abbinante A, et al (2022) The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. Supportive Care in Cancer","DOI":"10.1007\/s00520-022-06940-8"},{"key":"10302_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/JPER.21-0611","volume":"94","author":"MJ Kwoen","year":"2023","unstructured":"Kwoen MJ, Park JH, Kim KS et al (2023) Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: a national cohort-based study. J Periodontol 94:98\u2013107. https:\/\/doi.org\/10.1002\/JPER.21-0611","journal-title":"J Periodontol"},{"key":"10302_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/JCPE.13769","volume":"50","author":"D Trindade","year":"2023","unstructured":"Trindade D, Carvalho R, Machado V et al (2023) Prevalence of periodontitis in dentate people between 2011 and 2020: a systematic review and meta-analysis of epidemiological studies. J Clin Periodontol 50:604\u2013626. https:\/\/doi.org\/10.1111\/JCPE.13769","journal-title":"J Clin Periodontol"},{"key":"10302_CR38","doi-asserted-by":"publisher","DOI":"10.47895\/AMP.VI0.7630","volume":"58","author":"MCU Garcia","year":"2024","unstructured":"Garcia MCU, de la Vega SAF, Yanga-Mabunga MST (2024) Periodontal status of Filipino older adults in the Focused Interventions for FRAIL Older Adults Research and Development Program (FITforFRAIL): a cross-sectional study. Acta Med Philipp 58:64. https:\/\/doi.org\/10.47895\/AMP.VI0.7630","journal-title":"Acta Med Philipp"},{"key":"10302_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.JDSR.2021.11.005","volume":"58","author":"IE Ali","year":"2021","unstructured":"Ali IE, Sumita Y (2021) Medication-related osteonecrosis of the jaw: Prosthodontic considerations. Jpn Dent Sci Rev 58:9. https:\/\/doi.org\/10.1016\/J.JDSR.2021.11.005","journal-title":"Jpn Dent Sci Rev"},{"key":"10302_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/S40729-021-00323-0","author":"M Kawahara","year":"2021","unstructured":"Kawahara M, Kuroshima S, Sawase T (2021) Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent. https:\/\/doi.org\/10.1186\/S40729-021-00323-0","journal-title":"Int J Implant Dent"},{"key":"10302_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/PH13120467","volume":"2020","author":"S Toriumi","year":"2020","unstructured":"Toriumi S, Kobayashi A, Uesawa Y (2020) Comprehensive study of the risk factors for medication-related osteonecrosis of the jaw based on the Japanese Adverse Drug Event Report database. Pharmaceuticals 2020:467. https:\/\/doi.org\/10.3390\/PH13120467","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10302_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02225-2","volume":"15","author":"M Kujanp\u00e4\u00e4","year":"2025","unstructured":"Kujanp\u00e4\u00e4 M, Vuollo V, Tiisanoja A et al (2025) Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population. Sci Rep 15(1):17377. https:\/\/doi.org\/10.1038\/s41598-025-02225-2","journal-title":"Sci Rep"},{"key":"10302_CR43","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/S00784-021-04261-4","volume":"26","author":"A Wick","year":"2022","unstructured":"Wick A, Bankosegger P, Otto S et al (2022) Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab. Clin Oral Investig 26:2839\u20132852. https:\/\/doi.org\/10.1007\/S00784-021-04261-4","journal-title":"Clin Oral Investig"},{"key":"10302_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/S10006-025-01383-X","author":"H Sakuma","year":"2025","unstructured":"Sakuma H, Kanemaru H, Kurokawa A et al (2025) Prevalence of MRONJ in patients treated with antiresorptive agents for glucocorticoid-induced osteoporosis. Oral Maxillofac Surg. https:\/\/doi.org\/10.1007\/S10006-025-01383-X","journal-title":"Oral Maxillofac Surg"},{"key":"10302_CR45","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575. https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","journal-title":"J Oral Maxillofac Surg"},{"key":"10302_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T et al (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137\u2013145. https:\/\/doi.org\/10.1093\/annonc\/mdn526","journal-title":"Ann Oncol"},{"key":"10302_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/ANNONC\/MDN554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C et al (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117\u2013120. https:\/\/doi.org\/10.1093\/ANNONC\/MDN554","journal-title":"Ann Oncol"},{"key":"10302_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ANNONC\/MDR039","volume":"23","author":"AM Vandone","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M et al (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193\u2013200. https:\/\/doi.org\/10.1093\/ANNONC\/MDR039","journal-title":"Ann Oncol"},{"key":"10302_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA et al (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 67:2\u201312. https:\/\/doi.org\/10.1016\/j.joms.2009.01.009","journal-title":"J Oral Maxillofac Surg"},{"key":"10302_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/J.JCMS.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Tr\u00f6ltzsch M, Jambrovic V et al (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg 43:847\u2013854. https:\/\/doi.org\/10.1016\/J.JCMS.2015.03.039","journal-title":"J Craniomaxillofac Surg"},{"key":"10302_CR51","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ODI.13556","volume":"27","author":"O Ristow","year":"2021","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Moratin J et al (2021) Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake-a randomized pilot trial. Oral Dis 27:532\u2013546. https:\/\/doi.org\/10.1111\/ODI.13556","journal-title":"Oral Dis"},{"key":"10302_CR52","doi-asserted-by":"publisher","unstructured":"He L, Sun X, Liu Z, et al (2020) Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. International Journal of Oral Science 2020 12:1 12:1\u201311. https:\/\/doi.org\/10.1038\/s41368-020-00093-2","DOI":"10.1038\/s41368-020-00093-2"},{"key":"10302_CR53","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.4317\/MEDORAL.24197","volume":"26","author":"MM Romero-Ruiz","year":"2021","unstructured":"Romero-Ruiz MM, Romero-Serrano M, Serrano-Gonz\u00e1lez A et al (2021) Proposal for a preventive protocol for medication-related osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal 26:e314. https:\/\/doi.org\/10.4317\/MEDORAL.24197","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10302_CR54","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/S40001-024-01912-6\/FIGURES\/1","volume":"29","author":"H Byrne","year":"2024","unstructured":"Byrne H, O\u2019Reilly S, Weadick CS et al (2024) How we manage medication-related osteonecrosis of the jaw. Eur J Med Res 29:402. https:\/\/doi.org\/10.1186\/S40001-024-01912-6\/FIGURES\/1","journal-title":"Eur J Med Res"},{"key":"10302_CR55","doi-asserted-by":"publisher","unstructured":"Alblazi K, Nabil S, Tumian NR, et al (2024) Potential role of comprehensive dental care in preventing medication related osteonecrosis of the jaw (MRONJ): a single centre study. BMC Oral Health 24. https:\/\/doi.org\/10.1186\/S12903-024-05081-0,","DOI":"10.1186\/S12903-024-05081-0"},{"key":"10302_CR56","doi-asserted-by":"publisher","DOI":"10.1051\/MBCB\/2021035","volume":"27","author":"S Beaudouin","year":"2021","unstructured":"Beaudouin S, Scailteux LM, Lefeuvre C et al (2021) Jaw osteonecrosis in patients treated with denosumab 120 mg with regular dental monitoring: 4-year retrospective study. J Oral Med Oral Surg 27:47. https:\/\/doi.org\/10.1051\/MBCB\/2021035","journal-title":"J Oral Med Oral Surg"},{"key":"10302_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/S00520-025-09314-Y","author":"S Beaumont","year":"2025","unstructured":"Beaumont S, Liu A, Hull K (2025) A retrospective cohort study of the oral healthcare needs of cancer patients. Support Care Cancer. https:\/\/doi.org\/10.1007\/S00520-025-09314-Y","journal-title":"Support Care Cancer"},{"key":"10302_CR58","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/CNCR.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S, Cheng KKF, Lalla RV et al (2020) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126:4423\u20134431. https:\/\/doi.org\/10.1002\/CNCR.33100","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10302-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10302-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10302-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:05:17Z","timestamp":1771275917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10302-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10302"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10302-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of University Hospital of Palermo \u201cP. Giaccone\u201d (approval number n. 01\/2022), and by the University Hospital of Messina \u201cG. Martino\u201d (6311\/2017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"135"}}